Company overview
What Recursion does
Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage “TechBio” company aiming to industrialize drug discovery using large-scale biological experimentation plus machine learning and simulation. The company describes its approach as “lab-in-the-loop,” where automated wet-lab experiments generate multimodal data that trains and is used by AI models to nominate targets, design molecular candidates, and support clinical development decisions through the Recursion Operating System (“Recursion OS”).